– CANADA, Calgary – Voyageur Minerals Ltd. (TSX: VM) today announced the appointment of a new director and implementation of its succession plan for Voyageur’s CEO role.
Effective July 1st, 2019, after four years of dedicated service, Mr. John Rucci has resigned his CEO and director positions. Mr. Rucci was instrumental in advancing projects in the Voyageur portfolio and Voyageur thanks him for his efforts with moving the Company forward.
In keeping with the Company’s defined succession plan, the Board of Directors has appointed Brent Willis as the new CEO of Voyageur. Brent Willis is a founder and has been with the Company since its inception. He has a proven track record bringing projects from the discovery of minerals to cash flow. Brent has a proven leadership style that focuses on ethics, collaboration, teamwork, and profitability with the goal of ensuring shareholders’ interests form the foundation for all business decisions in creating the maximum return on investment value possible.
Voyageur is pleased to announce that Trent Abraham has been appointed as a director of Voyageur. Trent is a proven leader, senior executive, entrepreneur, consultant, and owner with over 31 years of success in energy services, oil & gas, mining, agriculture, blending and manufacturing, chemicals, global procurement and distribution, logistics and freight. Trent is currently the COO and President of Midwestern Mud and SOS Environmental. He also has an advisory role with Emprada Minerals LLC., a global mineral company. Trent has held senior executive positions at Emprada Minerals, Brichem Corporation / Brichem Supply Ltd., Sodium Solutions, Millennium Technologies, Ltd., Sun Coast Materials and Spirit Mountain Environmental.
About Voyageur
Voyageur Minerals Ltd. is a Canadian public company listed on the TSX Venture Exchange under the trading symbol VM. Voyageur is focused on the development of barite and iodine API minerals for the pharmaceutical market.
Near-term cash flow will be achieved through its recently signed joint venture with a world-class pharmaceutical manufacturer, Chief Medical Supply Ltd., for turnkey manufacturing, bottling and distribution of barium and iodine radiopharmaceuticals for MRI, X-ray and CT scan applications.
Voyageur owns 100% interest in three Barium Sulfate deposits including two properties suitable in grade for the industrial barite market place, including interests in a high-grade iodine, lithium & bromine brine project in Utah, USA.
For more information: https://voyageurminerals.ca
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
